
New #JITC position article and guideline: Priorities for local immunotherapy research and drug development jitc.bmj.com/content/14/3/e… @jasonlukemd @StrandTx
Russell Pachynski
1.6K posts

@RPachynski
Associate Professor, Director of GU Oncology Research, Division of Oncology, Washington University STL; Tumor immunology/immunotherapy; views my own

New #JITC position article and guideline: Priorities for local immunotherapy research and drug development jitc.bmj.com/content/14/3/e… @jasonlukemd @StrandTx










Great 40 hrs for med students on “eat your fruits and vegetables, eliminate fried food as much as possible, avoid most processed food, and limit red meat as well as alcohol.” I’m sure that will fix our obesity problem!

Happy #FollowFriday! Be sure to follow Neeraj Agarwal, MD (@neerajaiims), medical oncologist and Presidential Endowed Chair @HuntsmanCancer, Editor-in-Chief of @ASCO Daily News and a leading voice in oncology!



Nice shirts! Safe travels all!




So fun to get together this weekend in Boston for band camp with #TheCheckpoints! Thanks to @sitcancer and The Humphrey family! Now getting back to Tampa ahead of the blizzard! @jasonlukemd @wolchokj @FerranPrat5 @RPachynski @sitcancer @ipimama123 @BReinfeld @DocsWhoRock #docswhorock #bandcamp

Combination of AR-targeted therapy and PARP inhibitors shows no synergy in HR-proficient prostate cancer. Contrary to earlier models, AR inhibition does not regulate DNA repair or improve the response to PARP inhibitors. These findings suggest that patients with HR-proficient tumors may not derive significant benefit from this specific combination. @PNASNews @APCCC_Lugano @EricTopol @OncoAlert @OncBrothers pnas.org/doi/epdf/10.10…

We are excited to hear from @RPachynski from @WashUDeptMed tomorrow, 1/29 for Grand Rounds! "Updates in Prostate Cancer Immunotherapy"

Lucky to be in the room and hear such thoughtful input that comes from years of experience!

Love this team and so proud of our residents. Incredible to see their accomplishments.


A year ago today we lost @felixfengmd and I think of him every day. We know you’re up there cracking a joke, dreaming up the next big paper or or grant or company, having a milk tea, or about to call us at an inopportune time about something actually quite important.
